These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 220548)

  • 1. Nephrogenous cyclic AMP as a parathyroid function test.
    Broadus AE
    Nephron; 1979; 23(2-3):136-41. PubMed ID: 220548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the intravenous administration of calcium on nephrogenous cyclic AMP: use as a parathyroid suppression test.
    Broadus AE; Deftos LJ; Bartter FC
    J Clin Endocrinol Metab; 1978 Mar; 46(3):477-87. PubMed ID: 221521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Suppressibility of parathyroid function in primary hyperparathyroidism as estimated by nephrogenous cyclic AMP (author's transl)].
    Sohn HE; Yumita S; Unakami H; Miura R; Furukawa Y
    Nihon Naibunpi Gakkai Zasshi; 1982 Feb; 58(2):110-21. PubMed ID: 6282661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maximal PTH secretory rate and set point for calcium in normal subjects and patients with primary hyperparathyroidism. In vivo studies.
    Gardin JP; Patron P; Fouqueray B; Prigent A; Paillard M
    Miner Electrolyte Metab; 1988; 14(4):221-8. PubMed ID: 2850460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum ionized calcium, nephrogenous and total urinary cyclic AMP and urinary phosphate in normal subjects.
    Thode J; Holmegaard SN; Siggaard-Andersen O
    Scand J Clin Lab Invest; 1984 Apr; 44(2):111-8. PubMed ID: 6326252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrogenous cyclic adenosine monophosphate as a parathyroid function test.
    Broadus AE; Mahaffey JE; Bartter FC; Neer RM
    J Clin Invest; 1977 Oct; 60(4):771-83. PubMed ID: 197123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiological studies in idiopathic hypercalciuria: use of an oral calcium tolerance test to characterize distinctive hypercalciuric subgroups.
    Broadus AE; Dominguez M; Bartter FC
    J Clin Endocrinol Metab; 1978 Oct; 47(4):751-60. PubMed ID: 233682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone does not increase nephrogenous cyclic AMP excretion by the dog.
    Fox J; Heath H
    Endocrinology; 1980 Dec; 107(6):2124-5. PubMed ID: 6253291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of the determination of nephrogenous cyclic AMP in the diagnosis of primary hyperparathyroidism].
    Bill G; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1983 Mar; 113(9):327-30. PubMed ID: 6302835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrogenous cyclic AMP and plasma parathyroid hormone in hypercalcaemia: the influence of renal function.
    Bill G; Jacquet AF; Burckhardt P
    Eur J Clin Invest; 1984 Jun; 14(3):227-32. PubMed ID: 6088250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possibility of elevated parathyroid function in patients with calcium-containing nephrolithiasis as compared with normal controls.
    Kitamura T; Hirano Y; Ueda D; Niijima T
    Eur Urol; 1987; 13(1-2):90-9. PubMed ID: 3034619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal cyclic adenosine monophosphate: an accurate index of parathyroid function.
    Drezner MK; Neelon FA; Curtis HB; Lebovitz HE
    Metabolism; 1976 Oct; 25(10):1103-12. PubMed ID: 184364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intravenous glucagon on the urinary excretion of adenosine 3',5'-monophosphate in man and in rats. Evidence for activation of renal adenylate cyclase and formation of nephrogenous cAMP.
    Rubinger D; Wald H; Friedlaender MM; Silver J; Popovtzer MM
    Miner Electrolyte Metab; 1988; 14(4):211-20. PubMed ID: 2850459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal responsiveness of nephrogenous cyclic AMP excretion following intravenously administered calcium in normocalcaemic squamous cell cancer patients.
    Naafs MA; Hackeng WH; Koorevaar G; Silberbusch J
    Bone Miner; 1988 Jul; 4(3):289-98. PubMed ID: 2847840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A spot sample test for the estimation of urinary or nephrogenous cAMP in the evaluation of parathyroid function.
    Kraiem Z; Glaser B; Rosenzweig A; Sheinfeld M; Ben-Ari J
    Nephron; 1983; 35(4):264-6. PubMed ID: 6316183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urine calcium excretion, nephrogenous cyclic-adenosine monophosphate and serum parathyroid hormone levels in patients with essential hypertension.
    Papagalanis ND; Skopelitis P; Kourti A; Kostogianni G; Karabatsos A; Gennadiou M; Thomas S; Samartzis M; Mountokalakis T
    Nephron; 1991; 59(2):226-31. PubMed ID: 1659670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium potentiates the cyclic nucleotide and phosphaturic response to parathyroid hormone infusion.
    Bikle DD; Herman RH
    J Clin Endocrinol Metab; 1983 Jan; 56(1):11-7. PubMed ID: 6292254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonautonomy of parathyroid hormone and urinary cyclic AMP in primary hyperparathyroidism.
    Monchik JM; Wray HL; Schaaf M; Earll JM
    Am J Surg; 1977 Apr; 133(4):498-505. PubMed ID: 192097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria.
    Pak CY; Oata M; Lawrence EC; Snyder W
    J Clin Invest; 1974 Aug; 54(2):387-400. PubMed ID: 4367891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of adenosine 3',5'-monophosphate excretion and an oral calcium tolerance test in the diagnosis of mild primary hyperparathyroidism.
    Madvig P; Young G; Marcus R
    J Clin Endocrinol Metab; 1984 Mar; 58(3):480-7. PubMed ID: 6319454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.